Shuwen Biotech
333 Changhong Dongjie, Building 3,
Deqing
Zhejiang
313200
China
Tel: 650-260-3259
Website: http://www.shuwenbiotech.com/
Email: info@shuwendx.cn
About Shuwen Biotech
Based in China and led by U.S. diagnostic industry veterans, Shuwen Biotech is engaged in licensing and developing innovative diagnostic products and services for disease prevention, diagnosis and personalized medicine, and strives to offer in China a comprehensive menu of the most innovative diagnostic products and services for improved disease prediction, screening, diagnosis, prognosis and treatment.LEADERSHIP:
CEO: Jay Z. Zhang, MS, JD
CSO: Benjamin Zhou, PhD
PRODUCTS:
All Products
12 articles about Shuwen Biotech
-
BioSpace Global Roundup, Feb. 27
2/27/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations. -
BioSpace Global Roundup, Oct. 24
10/24/2019
Life sciences companies from across Europe and Asia provide updates on their business and pipelines. -
Shuwen Biotech Designated as an International Cooperation Base for Medical Diagnostic Technologies
10/23/2019
Shuwen Biotech announced that it has been designated as an International Cooperation Base for Novel Biomarkers and Innovative Diagnostic Technologies by authorities in Zhejiang Province, China.
-
BioSpace Movers and Shakers for Dec. 10
12/10/2018
Biotech and pharma companies strengthen their leadership teams with these appointments. Who made power moves in the industry this past week? -
Shuwen Biotech Wins at the 7th Annual China Innovation and Entrepreneurship Competition
12/7/2018
Shuwen Biotech announces its winning of an outstanding award in the national finals for the 7th Annual Innovation and Entrepreneurship organized by Chinese Ministry of Science and Technology held on November 14
-
Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs
9/17/2018
Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs
-
Shuwen Biotech's Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit
7/19/2018
Shuwen is proud to announce that it has successfully passed the 2018 biannual review and was awarded a two-year extension of the CAP accreditation.
-
Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development
5/7/2018
Abcam today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the development and commercialization of companion diagnostics (CDx).
-
Shuwen Biotech Receives CE Mark For EGFR Mutation PCR Kit For Lung Cancer
9/19/2017
-
Shuwen Biotech Release: Company Receives EN ISO 13485 Certification
1/13/2017
-
Shuwen Biotech's Clinical Lab Receives Accreditation From College of American Pathologists
9/23/2016
-
Shuwen Biotech Release: Chinese FDA Grants MammaTyper Innovative Product Status For Expedited Approval
8/19/2016